USFDA approves Biocon Biologics Yesintek for Crohn's disease, Ulcerative Colitis, Plaque Psoriasis, Psoriatic Arthritis Ruchika Sharma2 Dec 2024 11:30 AM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced that the U.S. Food ...
First American Gastroenterological Association living guideline for moderate-to-severe ulcerative colitis Dr. Kamal Kant Kohli26 Nov 2024 8:15 PM ISTThe American Gastroenterological Association (AGA) has released a new clinical guideline on the pharmacological management of moderate-to-severe...
Biocon Biologics secures market entry for Bmab 1200 in Europe, UK, Canada, Japan Ruchika Sharma29 Aug 2024 12:30 PM ISTBangalore: Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and a subsidiary of Biocon Ltd, announced today that the...
Endoscopic treatment approaches for inflammatory bowel diseases: old friends and new weapons Dr. Kamal Kant Kohli26 Aug 2024 1:15 AM ISTInflammatory bowel diseases (IBD), comprising Crohn's disease (CD) and ulcerative colitis (UC), are chronic inflammatory conditions affecting the...
Novel PET imaging tool identifies early signs of IBD and predicts response to treatment, suggests study Dr. Kamal Kant Kohli13 Aug 2024 8:00 AM ISTA newly developed imaging method, granzyme B PET, can non-invasively detect inflammatory bowel disease (IBD) and provide a real-time picture of active...
Sandoz unveils biosimilar Pyzchiva across Europe to treat chronic inflammatory diseases Ruchika Sharma28 July 2024 10:30 AM ISTBasel: Sandoz has announced the launch of Pyzchiva (ustekinumab) across Europe. Pyzchiva, developed and registered by Samsung Bioepis, a ustekinumab...
JnJ seeks USFDA approval for Tremfya for moderately to severely active Crohn's disease Ruchika Sharma22 Jun 2024 2:21 PM ISTSpring House: Johnson & Johnson has announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug...
JnJ submits regulatory applications to EMA for Tremfya for treatment of patients with ulcerative colitis, Crohn's disease Ruchika Sharma5 May 2024 1:30 PM ISTBeerse: Janssen-Cilag International NV, a Johnson & Johnson company, has announced it has submitted applications to the European Medicines...
Takeda gets USFDA nod for Entyvio subcutaneous administration for Crohn's disease Ruchika Sharma21 April 2024 10:00 AM ISTOsaka: Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO (vedolizumab) subcutaneous (SC)...
Healthy diet early in life may protect against inflammatory bowel disease later Dr. Kamal Kant Kohli3 Feb 2024 2:00 AM ISTHaving a high dietary intake of fish and vegetables at 1 year of age, and a low intake of sugar beverages, seems to protect against inflammatory bowel...
Mood interventions may reduce inflammation in Crohn's and Colitis Dr. Kamal Kant Kohli27 Jan 2024 2:00 AM ISTNew King's College London research reveals that interventions which improve mood can reduce levels of inflammation in people with inflammatory bowel...
Vitamin D supplemens may improve inflammation in Irritable bowel disease: Study Niveditha Subramani5 Dec 2023 10:00 AM ISTIrritable bowel disease (IBD) is one of the most commonly presented by chronic abdominal pain, discomfort, bloating, and alteration of bowel habits...
